- US-listed companies
- VBI Vaccines Inc
VBI Vaccines IncVBIV
Market cap
$1.55M
P/E ratio
| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | |
| Revenues, net | 1 | 1 | 3 | 2 | 1 | 1 | 1 |
| Cost of revenues | - | - | - | - | - | 11 | 11 |
| Research and development | 10 | 21 | 38 | 26 | 15 | 20 | 16 |
| Sales, general and administrative | - | - | - | - | - | - | 56 |
| Total operating expenses | 25 | 38 | 64 | 55 | 45 | 69 | 83 |
| Loss from operations | -25 | -37 | -60 | -52 | -44 | -68 | -82 |
| Interest expense, net of interest income | 0 | - | 3 | 2 | 3 | - | 4 |
| Foreign exchange (loss) gain | 0 | 1 | -1 | -0 | 0 | 3 | -27 |
| Loss before income taxes | -25 | -39 | -64 | -55 | -46 | -70 | -113 |
| Income tax expense | -2 | -0 | - | - | - | - | - |
| NET LOSS | -23 | -39 | -64 | -55 | -46 | -70 | -113 |
| Other comprehensive income (loss) | - | - | - | - | 2 | -3 | 23 |
| COMPREHENSIVE LOSS | -25 | -35 | -69 | -51 | -44 | -73 | -90 |
| Net loss per share of common shares, basic and diluted | - | - | - | - | - | - | -0.44 |